Meeting Standard 7

How do these activities assist Burnside Hospital to meet Standard 7?

The audits assist with achieving NSQHS Standard 7.2 and 7.4:

7.2 Undertaking a regular, comprehensive assessment of blood and blood product systems to identify risks to patient safety and taking action to reduce risks

7.2.1 The risks associated with transfusion practices and clinical use of blood and blood products are regularly assessed

7.2.2 Action is taken to reduce the risks associated with transfusion practices and the clinical use of blood and blood products

7.4 Undertaking quality improvement activities to improve the safe management of blood and blood products.

7.4.1 Quality improvement activities are undertaken to reduce the risks of patient harm from transfusion practices and the clinical use of blood and blood products

Reduced blood movement assists with achieving with NSQHS Standard 7.8:

7.8 Minimising unnecessary wastage of blood and blood products

7.8.2 Action is taken to minimise wastage of blood and blood products.

The reduced amount of cross-matched blood assists with achieving NSQHS Standard 7.7:

7.7 Ensuring the receipt, storage, collection and transport of blood and blood products within the organisation are consistent with best practice and/or guidelines

7.7.1 Regular review of the risks associated with receipt, storage, collection and transport of blood and blood products is undertaken

7.7.2 Action is taken to reduce the risk of incidents arising from the use of blood and blood products control systems

The culture changes assist with achieving NSQHS Standard 7.1 and 7.2:

7.1 Developing governance systems for safe and appropriate prescription, administration and management of blood and blood products

7.1.3 Action is taken to increase the safety and appropriateness of prescribing and clinically using blood and blood products

7.2 Undertaking a regular, comprehensive assessment of blood and blood product systems to identify risks to patient safety and taking action to reduce risks

7.2.1 The risks associated with transfusion practices and clinical use of blood and blood products are regularly assessed

7.2.2 Action is taken to reduce the risks associated with transfusion practices and the clinical use of blood and blood products